Clinical trials in Leverkusen

Innovative studies focusing on colorectal cancer treatment approaches, including pre-operative and post-resection therapies. Research encompasses both early-stage and metastatic disease management.

• Advanced colon cancer treatment protocols
• Metastatic disease management
• Post-resection therapy evaluation

Multiple trials are investigating personalized treatment strategies based on disease staging and biomarkers.

Cutting-edge research examining treatments for triple-negative breast cancer and hormone receptor-positive disease, with focus on neoadjuvant and adjuvant therapies.

• Novel combination therapies
• Personalized treatment approaches
• Early-stage disease management

Trials aim to improve survival rates and treatment outcomes through targeted therapeutic strategies.

Comprehensive studies addressing heart failure and acute coronary conditions, testing innovative medications for improved patient outcomes.

• Heart failure treatment optimization
• Post-heart attack therapy
• Cardiovascular risk reduction

Research focuses on reducing mortality rates and improving quality of life for cardiac patients.

Advanced research in bladder cancer and prostate cancer, evaluating new treatment options for high-risk patients.

• Non-muscle-invasive bladder cancer therapy
• Post-prostatectomy treatment
• Risk-adapted therapeutic approaches

Studies aim to improve disease-free survival and reduce recurrence rates.

Innovative treatment approaches for B-cell lymphoma, focusing on chemotherapy-light combinations and targeted therapies.

• Novel antibody combinations
• Age-adapted treatment protocols
• Immunotherapy applications

Research emphasizes improving outcomes for elderly patients unsuitable for standard therapies.